Advertisement

Topics

AstraZeneca's, MedImmune's Imfinzi granted breakthrough therapy status

05:12 EDT 31 Jul 2017 | SmartBrief

The FDA has granted breakthrough therapy designation to AstraZeneca's and MedImmune's Imfinzi, or durvalumab, being developed -More

Original Article: AstraZeneca's, MedImmune's Imfinzi granted breakthrough therapy status

NEXT ARTICLE

More From BioPortfolio on "AstraZeneca's, MedImmune's Imfinzi granted breakthrough therapy status"

Quick Search
Advertisement
 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...